×
About 338 results

ALLMedicine™ Pediatric Hodgkin Lymphoma Center

Research & Reviews  153 results

Subsequent neoplasms in pediatric Hodgkin lymphoma.
https://doi.org/10.1182/blood.2021011303
Blood

Mar 18th, 2021 - Subsequent neoplasms in pediatric Hodgkin lymphoma.|2021||

Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morb...
https://doi.org/10.1200/JCO.20.01186
Journal of Clinical Oncology : Official Journal of the Am... Oeffinger KC, Stratton KL et. al.

Feb 25th, 2021 - To determine the incidence of serious chronic health conditions among survivors of pediatric Hodgkin lymphoma (HL), compare by era of therapy and by selected cancer therapies, and provide estimates of risks associated with contemporary therapy. As...

Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Imp...
https://doi.org/10.1002/pbc.28903
Pediatric Blood & Cancer; Kurch L, Mauz-Körholz C et. al.

Feb 4th, 2021 - In the EuroNet Pediatric Hodgkin Lymphoma (EuroNet-PHL) trials, decision on Waldeyer's ring (WR) involvement is usually based on clinical assessment, that is, physical examination and/or nasopharyngoscopy. However, clinical assessment only evaluat...

LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940566
Leukemia & Lymphoma; Moerdler S, Ewart M et. al.

Oct 28th, 2020 - LAG-3, through interaction with a variety of ligands, regulates T cell function via inhibition of T cell proliferation and activation. It has been demonstrated to be overexpressed on tumor infiltrating lymphocytes (TILs) of a variety of cancers wi...

Secondary Hypertrophic Osteoarthropathy in Pediatric Hodgkin lymphoma.
https://doi.org/10.1002/art.41445
Arthritis & Rheumatology (Hoboken, N.J.); Tam HHY, Laxer RM

Jul 20th, 2020 - Secondary Hypertrophic Osteoarthropathy in Pediatric Hodgkin lymphoma.|2020|Tam HHY,Laxer RM,|complications,diagnostic imaging,complications,diagnostic imaging,diagnostic imaging,etiology,

see more →

Guidelines  1 results

Implementation of contemporary radiation therapy planning concepts for pediatric Hodgki...
https://doi.org/10.1016/j.prro.2014.05.003
Practical Radiation Oncology; Hodgson DC, Dieckmann K et. al.

Nov 21st, 2014 - The optimal management of children with Hodgkin lymphoma (HL) should limit the risk of treatment-related toxicity without compromising disease control. Consequently, increasing effort is being directed to retaining the demonstrated efficacy of rad...

see more →

Clinicaltrials.gov  173 results

Subsequent neoplasms in pediatric Hodgkin lymphoma.
https://doi.org/10.1182/blood.2021011303
Blood

Mar 18th, 2021 - Subsequent neoplasms in pediatric Hodgkin lymphoma.|2021||

Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morb...
https://doi.org/10.1200/JCO.20.01186
Journal of Clinical Oncology : Official Journal of the Am... Oeffinger KC, Stratton KL et. al.

Feb 25th, 2021 - To determine the incidence of serious chronic health conditions among survivors of pediatric Hodgkin lymphoma (HL), compare by era of therapy and by selected cancer therapies, and provide estimates of risks associated with contemporary therapy. As...

Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Imp...
https://doi.org/10.1002/pbc.28903
Pediatric Blood & Cancer; Kurch L, Mauz-Körholz C et. al.

Feb 4th, 2021 - In the EuroNet Pediatric Hodgkin Lymphoma (EuroNet-PHL) trials, decision on Waldeyer's ring (WR) involvement is usually based on clinical assessment, that is, physical examination and/or nasopharyngoscopy. However, clinical assessment only evaluat...

LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940566
Leukemia & Lymphoma; Moerdler S, Ewart M et. al.

Oct 28th, 2020 - LAG-3, through interaction with a variety of ligands, regulates T cell function via inhibition of T cell proliferation and activation. It has been demonstrated to be overexpressed on tumor infiltrating lymphocytes (TILs) of a variety of cancers wi...

Diagnosing Hodgkin Lymphoma in Kids Requires Biopsy, Immunohistochemistry: Guidelines
https://www.staging.medscape.com/viewarticle/939302

Oct 18th, 2020 - NEW YORK (Reuters Health) - The diagnosis of pediatric Hodgkin lymphoma requires an excisional or incisional biopsy and immunohistochemistry (IHC) evaluation, and its management depends largely on the clinical stage and risk group, according to ne...

see more →

News  11 results

Diagnosing Hodgkin Lymphoma in Kids Requires Biopsy, Immunohistochemistry: Guidelines
https://www.staging.medscape.com/viewarticle/939302

Oct 18th, 2020 - NEW YORK (Reuters Health) - The diagnosis of pediatric Hodgkin lymphoma requires an excisional or incisional biopsy and immunohistochemistry (IHC) evaluation, and its management depends largely on the clinical stage and risk group, according to ne...

Diagnosing Hodgkin Lymphoma in Kids Requires Biopsy, Immunohistochemistry: Guidelines
https://www.medscape.com/viewarticle/939302

Oct 18th, 2020 - NEW YORK (Reuters Health) - The diagnosis of pediatric Hodgkin lymphoma requires an excisional or incisional biopsy and immunohistochemistry (IHC) evaluation, and its management depends largely on the clinical stage and risk group, according to ne...

RT Add-On May Boost Survival in Pediatric Hodgkin Lymphoma
https://www.medpagetoday.com/hematologyoncology/lymphoma/77332

Jan 9th, 2019 - Action Points Combined modality therapy (chemotherapy plus radiation therapy) in pediatric Hodgkin lymphoma (HL) patients, compared with chemotherapy alone, resulted in an improved 5-year overall survival (OS) benefit of 2.8%. Understand that the ...

Adding RT Tied to Better Survival in Pediatric Hodgkin Lymphoma
https://www.medpagetoday.com/hematologyoncology/lymphoma/77251

Jan 3rd, 2019 - Combined modality therapy (CMT) -- chemotherapy plus radiation therapy -- was associated with improved survival in young Hodgkin lymphoma patients compared with chemotherapy alone, an observational study found. At a median follow-up of 61.8 months...

Long-term health burden of Hodgkin lymphoma treatment
https://www.mdedge.com/hematology-oncology/article/187182/lymphoma-plasma-cell-disorders/long-term-health-burden-hodgkin-lymphoma
HT Staff

Jul 26th, 2016 - Nickhill Bhakta, MD Photo courtesy of St. Jude Children’s Research Hospital and Seth Dixon New research has shown that survivors of pediatric Hodgkin lymphoma (HL) are more likely to have chronic cardiovascular conditions than adults who did not h.

see more →